Director of Public Health approved recommendations on 25/11/2024. Additional funding was authorised for Change Grow Live (CGL) from the Rough Sleeping Drug and Alcohol Treatment Grant and the Public Health Grant. This included funding for prolonged-release injectable buprenorphine, to cover a budget shortfall, and to cover an overspend against the Supplementary Substance Misuse Treatment and Recovery Grant.